Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.580
+0.050 (1.98%)
At close: Nov 22, 2024, 4:00 PM
2.600
+0.020 (0.78%)
After-hours: Nov 22, 2024, 4:24 PM EST
Vistagen Therapeutics Employees
As of March 31, 2024, Vistagen Therapeutics had 40 total employees, including 39 full-time and 1 part-time employees. The number of employees increased by 6 or 17.65% compared to the previous year.
Employees
40
Change (1Y)
6
Growth (1Y)
17.65%
Revenue / Employee
$21,900
Profits / Employee
-$989,125
Market Cap
71.84M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Rockwell Medical | 237 |
Metagenomi | 236 |
Exagen | 179 |
OptiNose | 132 |
VolitionRx | 110 |
Scilex Holding Company | 105 |
electroCore | 68 |
InspireMD | 66 |
VTGN News
- 9 days ago - Vistagen to Present at the Stifel 2024 Healthcare Conference - Business Wire
- 13 days ago - Vistagen Therapeutics, Inc. (VTGN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update - Business Wire
- 18 days ago - Vistagen to Present at the 2024 Neuroscience Education Institute Congress - Business Wire
- 22 days ago - Vistagen to Report Fiscal Year 2025 Second Quarter Results and Host Corporate Update Conference Call on November 7, 2024 - Business Wire
- 5 weeks ago - Vistagen Could Run Up Ahead Of Phase 3 Results In Social Anxiety Disorder - Seeking Alpha
- 6 weeks ago - Vistagen, The Goldie Hawn Foundation, and MindUP Students to Ring Nasdaq Closing Bell on World Mental Health Day - Business Wire
- 2 months ago - Vistagen Initiates PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder - Business Wire